// App-Quantinova.ai

THU0123 : DIABETES MELLITUS AND CARDIOVASCULAR RISK MANAGEMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS IN A LARGE INTERNATIONAL AUDIT

Researchers

Presenter

  • E. Ikdahl

Principal Investigators

  • S. Rollefstad

  • J. Sexton

  • B. Nellemann

  • G. Kitas

  • P. Van Riel

  • C. S. Crowson

  • I. Graham

  • A. G. Semb

Medical Centers

  • Diakonhjemmet Hospital, Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Oslo, Norway

  • Diakonhjemmet Hospital, Rheumatology Unit, Oslo, Norway

  • Dudley Group of Hospitals, NS Foundation Trust, Dudley, United Kingdom, Department of Rheumatology,, Dudley, United Kingdom

  • Radboud Hospital, Department of Rheumatology, Nijmegen, Netherlands

  • Mayo Clinic, Department of Health Sciences Research, Rochester, United States of America

  • University College Dublin, Dublin 4, Ireland

Locations

  • Norway

  • United Kingdom

  • Netherlands

  • United States

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Endocrine/metabolic Diseases (ME)

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

  • Diabetes

  • Hypertension

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Pfizer

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved